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Abstract
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Nicotine has several health hazards regarding carcinogenic potential. It also imparts
increased risk for respiratory, cardiovascular, and gastrointestinal disorders. Several
mechanisms have been proposed for the carcinogenic potential, including effects on cell
proliferation, inducing oxidative stress, DNA mutation, or inhibition of apoptosis. The
cotinine metabolite is generally thought to have effects similar to nicotine in some
experimental systems.
The purpose of this study was to assess the nicotine and cotinine cytotoxicity on
MRC-5 lung fibroblasts. The pulmonary fibroblasts were treated with various
concentrations of nicotine or cotinine (in the range 1 µM – 2 mM) for 24 or 48 h and
analyzed for cell viability by MTT test.
The results indicated that high nicotine concentrations (2 mM) induced marked cell
death (about 50%) in MRC-5 cell line. Cotinine showed lower toxicity than nicotine on
the MRC-5 cells. In contrast to nicotine treatment, cells treated with cotinine continued
to proliferate after the 48h incubation period.
 nicotine, cotinine, cytotoxicity, MRC-5, MTT-assay
✓

At concentrations similar to the levels observed in the plasma of smokers, nicotine and
cotinine were not cytotoxic on MRC-5 cell line

✓

Higher concentrations (2mM) of both nicotine and cotinine decreased the viability of
MRC-5 cells.

✓

Nicotine proved to be more cytotoxic than cotinine. Unlike nicotine, the proliferative
capacity of MRC-5 cells is maintained after 48 hours of cotinine treatment.
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Introduction
Smoking is the only cause of premature death that
can be totally prevented. Morbidity induced by tobacco
smoking refers in particular to diseases of the respiratory
system and the cardiovascular system. In addition,
increased prevalence of cancer at different levels in the
body, urinary tract damage, gastrointestinal disorders,
ocular damage, endocrine and metabolic alterations, and
adverse effects on pregnancy have been reported. An
alarming aspect is that smoking also affects the health of
non-smokers who are passively exposed to tobacco
smoke (1, 2).
Nicotine alkaloid is the major addictive component
of tobacco. Nicotine is a highly toxic compound that
exerts its effects on almost every organ and system in
the body. It is absorbed through the entire respiratory
tract, through the oral and nasal mucosa, into the
gastrointestinal tract, and even through the skin. In vivo,
nicotine is extensively metabolized by cytochrome P450
in the liver, to the major metabolite cotinine (Figure 1).
Cotinine metabolite has a relatively long half-life (~17
h) compared to nicotine (1–2 h) and it is used as a
biomarker for smoking, including passive smoking
(3,4).

Figure 1. Oxidative biotransformation of
nicotine to cotinine
The carcinogenic potential of nicotine is supported
by current studies. Many types of cancers, including
small-cell and non-small-cell lung carcinomas, head and
neck, gastric, pancreatic, colon, breast, cervical, urinary,
bladder, and kidney cancers have been associated with
nicotine (5).
Several studies indicate that nicotine is toxic and
addictive, but it is not carcinogenic (6).
Current in vitro and in vivo studies demonstrate that
nicotine and its main metabolite cotinine have tumorpromoting activities. In addition, tobacco smoke
contains a variety of proved carcinogens including
polycyclic
aromatic
hydrocarbons
(i.e.
3,4benzo(a)pyrenes), and tobacco-specific nitrosamines,
such
as
4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNK) and N’-nitrosonornicotine (NNN) (7).
The current research is focused on the molecular
mechanisms by which nicotine and tobacco smoke can
initiate tumor formation, influence cell cycle
progression and proliferation, and promote tumor

progression in multiple cancer types (7). The potential
of nicotine in inducing DNA mutations as a step towards
cancer initiation is still controversially discussed (8).
Nicotine was shown to have an important role in
regulating cellular processes such as proliferation,
differentiation, and migration. In normal cells, nicotine
can stimulate mechanisms consistent with cell
transformation and the early stages of cancer
development (9).
On in vitro systems, it has been demonstrated that
nicotine increased cell proliferation, inhibited apoptosis,
stimulated cancer cell growth, and enhanced or inhibited
angiogenesis. Nicotine was also reported to promote
tumor growth and metastasis in cancer xenograft models
(10).
Nicotine exerts its effects by activating the nicotinic
acetylcholine receptors (nAChRs) that are expressed in
neurons and neuromuscular junctions and in a wide
variety of non-neuronal cells, including those of
epithelial and endothelial origin.
Nicotine has been demonstrated to have tumorpromoting properties by activating the nAChRs; this
may result in activation of several signaling pathways
that can have tumorigenic effects. It has been shown that
nicotine (at concentrations similar to those in the
bloodstream of smokers, ranged from 10 nmol/L to 10
μmol/L) or tobacco-specific nitrosamines such as NNK
could induce proliferation in various in vitro cell culture
models, and this effect could be canceled by nAChR
antagonists (7).
Recent studies demonstrated that nicotine induces
multiple cancer cell proliferation via α7-nAChR
subunit. Thus, nicotine was shown to induce a dosedependent increase in proliferation of lung cancer cells,
breast cancer cells, and pancreatic cancer cells via α7nAChRs-mediated signal transduction pathways (11). In
addition, nicotine induced epithelial-to-mesenchymal
transition (EMT) in breast and lung cancer (11).
It has been demonstrated that nicotine induces cell
proliferation via α7-nAChR subunit in mouse lung
cancer and enhances the growth of tumors induced by
tobacco carcinogens. In addition, nicotine promotes regrowth and metastasis of tumors in mice (12).
Nicotine
was
demonstrated
to
promote
proliferation, invasion, and angiogenesis in tumor cells
while inhibiting apoptosis (13).
The cotinine metabolite was also shown to induce
tumor promotion in human lung adenocarcinoma cells
by inhibiting apoptosis and increasing cellular
proliferation (14).
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D2 = 1 mM; D3 = 750 µM; D4 = 500 µM; D5 = 100
µM; D6 = 10 µM and D7 = 1 µM.
For determining the optimal working dose and also
for evaluating the proliferation of the cells under
treatment with nicotine and cotinine, viability of the
pulmonary fibroblasts MRC-5 was assessed.
Cytotoxicity was determined by 3-(4,5-dimethylthiazol2-yl)-2,5 diphenyltetrazolium bromide (MTT) assay.
The quantitative colorimetric MTT is based on the
reduction of a yellow tetrazolium salt MTT to a blueviolet formazan in the culture medium. The reduction
reaction is made by the mytochondrial enzymes
(especially hydrogenase succinate) and is an index of the
cell/mitocondriale integrity. The formazan may be
solubilised with izopropanol or DMSO, and the optic
density (D.O.) of the solution obtained this way may be
spectrophotometrically evaluated at 550nm.
Briefly, the MRC-5 cells were seeded at a density
of 103 cells/well into 96-well microtiter plates in three
replicates and left for 24 hours to adhere. The next day,
the culture medium was replaced with a fresh one, which
contained different concentrations of nicotine or
cotinine followed by incubation for 24 or 48 hours. After
24 or 48 hours, the treatment was removed and the cell
mono-layers were incubated for 4 h with a 1 mg/ml MTT
Materials and method
solution in serum-free medium. The formazan crystals
This study was performed on the continuous cell formed, in the meantime, by the active metabolic cells,
line of pulmonary fibroblasts MRC-5 (ATCC – have been solubilised in DMSO, and the D.O. of the
American Type Culture Collection). According to the resulting solution was determined at 550 nm.
manufacturer's datasheet, these cells exhibit typical
Statistics
fibroblast morphology.
Quantitative data were processed and represented
To spread the culture, the cells were cultivated in
graphically
by means of the soft GraphPad Prism 3.03.
Eagle's Minimum Essential Medium (EMEM)
Data are expressed as mean ± SE (SEM). Grouped
supplemented with 1 % antibiotic/antimichotic
(ABAM) and 10% fetal bovine serum (SFB), put in data were compared with one-way ANOVA with
sterile culture vials. The cells were incubated at 37°C, in Bonferroni adjustment. P-values < 0.05 were considered
statistically significant.
humid atmosphere of 5% CO2 during the entire
There are conflicting reports regarding the
beneficial effects of nicotine and its main metabolite
cotinine on the human body. Cotinine has been reported
to have some pharmacologic activity that decreases
vascular resistance, decreases blood pressure in animals,
and affects cognitive performance (15).
Nicotine (10-7 – 10-5 M) and cotinine (10-6 – 10-8
M) exhibited neuroprotective properties in SH-SY5Y
neuroblastoma cell line. Cotinine also protected against
6-hydroxydopamine (6-OHDA)-induced cell damage in
neuroblastoma cells (16).
Studies have revealed the citotoxic effects of
nicotine in different experimental systems while there
are limited data regarding the citotoxic effects of
cotinine. Nicotine exerts dose- and time-dependent
cytotoxic effects on the mesenchymal stem cells derived
from human periodontium (17). Nicotine and cigarette
extract (CE) were demonstrated to induce cytotoxicity
in human embryonic lung fibroblast, MRC-9 (18).
The present study investigated the in vitro effects of
nicotine and cotinine on proliferation of MRC-5 cell
line, a diploid human cell culture line composed of
fibroblasts derived from normal lung tissue of a 14week-old male fetus.

experimental period. In order to multiply, the cells
adherent to the culture substrate were detached by
means of enzimatic treatment with trypsin at 80 %
confluency. Effectively, for the multiplication, the cells
were detached from the culture surface with a solution
of trypsin –EDTA. The cell sediment following the
centrifugation was re-suspended in fresh culture
medium, and the cell suspension was distributed in new
culture vials.
(-)-Nicotine (≥99%, Sigma-Aldrich) and (-)Cotinine (≥98%, Sigma-Aldrich) were used to prepare
stock solutions in DMSO. Both nicotine and cotinine
have been tested in the following dilutions: D1 = 2 mM,

Results
Dose screening
In order to examine if nicotine or cotinine is
cytotoxic to MRC-5 cells, the cell line was treated with
various concentrations of nicotine or cotinine in the
range 1 µM – 2 mM for 24 h and analyzed for cell
viability by MTT-assay.
Dose screening for nicotine has shown that the use
of a 2 mM dose lowers the viability of the cells to 50%
compared to the non-treated control, and the treatment
with concentrations which are lower or equal to 750 µM
does not induce modifications of the cell viability
(Figure 2). Lung fibroblast cell line MRC-5 was largely
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unaffected by the nicotine treatment in the range of
Evaluation of proliferative potential
concentration 1 µM – 750 µM. Therefore, following the
The evaluation of proliferative potential has shown
dose screening, the concentration of 1mM of nicotine that non-treated control MRC-5 cells proliferate
was selected for the further study of the cell significantly (p<0.0001) in culture for 48h (Figure 4).
proliferation.
Once exposed to the treatment with 1mM nicotine, the
proliferative potential of the MRC-5 cells is inhibited,
but we did not detect statistically significant changes
between the viability of the cells treated with 1 mM
nicotine for 24h and for 48h.
In terms of treatment with 2 mM cotinine, the
proliferative potential of the MRC-5 cells is inhibited
compared to the non-treated control, with statistically
significant differences (p<0.05) between the viability of
the cells treated with cotinine for 24h and 48h (Figure
4).

Figure 2. The viability of the MRC-5 cells
treated for 24h with nicotine D1 = 2 mM, D2
= 1 mM, D3 = 750 µM, D4 = 500 µM, D5 =
100 µM, D6 = 10 µM and D7 = 1 µM in
culture medium
The viability of the MRC-5 cells treated with
cotinine was unaffected in the range of concentration 1
µM – 1 mM (Figure 3). Cotinine showed lower toxicity
than nicotine on the MRC-5 cells. The dose screening
for cotinine shows that the use of a dose smaller or equal
to 1mM does not induce modifications of the cell
viability. Thus, following the dose screening, the
concentration of 2mM of cotinine was selected for the
further study of the cell proliferation.

Figure 4. The proliferative potential of MR-5
cells treated for 24h and 48h with 1 mM
ncotine or 2 mM cotinine (Nic = Nicotine; Cot
= Cotinine)
*** p<0.0001 control 48h versus control 24h;
* p<0.05 cotinine 48h versus cotinine 24h)
The results indicated that the MRC-5 cells treated
with 1mM nicotine do not proliferate after 48h of
treatment, in contrast to those treated with 2 mM
cotinine that retain some weak proliferative potential if
treated for 48h.

Discussions
Evidence confirms harmful effects of tobacco use
and nicotine. Smoking is demonstrated as a risk factor
for various types of cancer, including lung, oral cavity,
Figure 3. The viability of the MRC-5 cells
treated for 24 h with D1 = 2 mM, D2 = 1 mM,
D3 = 750 µM, D4 = 500 µM, D5 = 100 µM,
D6 = 10 µM si D7 = 1 µM cotinine in culture
medium

or breast cancer. Nicotine has been shown to have
tumor-promoting

activity.

In

addition,

growing

evidence suggests that the use of tobacco can reduce the
efficacy of cancer medicines and may increase the risk
of recurrence, while migration to other geographical
areas is able to influence the cancer incidence (19).
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In recent years, research has provided findings
regarding the mechanism of nicotine toxicity.
Furthermore, evaluation of the toxicological profile of
cotinine, the main metabolite of nicotine, is under
current investigation. Controversy over the toxicity of
cotinine continues. Cotinine is less lipophilic than
nicotine and has been found to be less cytotoxic than
nicotine on fibroblast (HFF), melanoma (SK-Mel/27),
and hepatoma (HepG2) cell lines (20). Nicotine and
cotinine were not cytotoxic to Chinese hamster ovary
(CHO) cells (21).
The present study evaluated the toxicity of nicotine
and its metabolite cotinine on normal human lung cell
line MRC-5. Limited data are published with respect to
the cytotoxic effects of nicotine and cotinine on normal
cells. Our study investigated the cytotoxic potential of
nicotine compared to cotinine on MRC-5 human lung
fibroblast cell line by using the MTT assay.
Our overall results are in line with studies

Cotinine was less cytotoxic than nicotine on MRC5 cell line. The results indicate that the MRC-5 cells
treated with 1mM nicotine do not proliferate after 48h
of treatment, in contrast to those treated with 2 mM
cotinine that retain weak proliferative potential if treated
for 48h.
The present study demonstrated that, at
physiologically relevant concentrations, both nicotine
and cotinine would have no significant toxic effect on
MRC-5 pulmonary fibroblasts. High concentrations
decreased the cell viability, and cotinine was proved to
be less toxic than nicotine in MRC-5 cells. In contrast to
nicotine treatment, cells treated with cotinine continue
to proliferate after 48h incubation period.

Conclusions
Our data indicate that, at concentrations similar to
those reported in the bloodstream of smokers, nicotine
and cotinine have not been shown to be cytotoxic on the

investigating the cytotoxicity of nicotine in various in tested MRC-5 normal human lung cell line.
The viability of the MRC-5 cells treated with higher
vitro systems. Nicotine, at a concentration of 1μM, was
shown to exert a minor effect on the viability of MRC-5 concentration of nicotine or cotinine was decreased, and
normal fibroblasts, while the proliferation of both nicotine was shown to be more toxic than cotinine.
The results of the study provide additional
human lung cancer cell lines A549 and SKMES-1 (13%
information on the toxicity of cotinine and nicotine on
for A549 and 14% for SKMES-1) was slightly enhanced
normal cells.
(22).
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